Moreover, Martignoni et al (2005) have suggested that IL-6 overexpression in cachectic pancreatic cancer patients is related to the ability of certain IL-6 producing tumours to sensitise PBMC and induce IL-6 expression in PBMCs. This evidence concerns the gene IL6 and familial pancreatic carcinoma.